General
publicado em 04/10/2012 às 19h13:00
   Dê o seu voto:

Anvisa increased by 60% the release of generics in 2011, says minister

Delay in release of supplies to the market by the agency was the subject of the document tabled yesterday by the government Interfarma

 
font size
A-
A+

Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt,      consult the original text.



The Health Minister Alexandre Padilha said today (4) that the contracts between the folder and the National Health Surveillance Agency (ANVISA) have prioritized the release of generics, biotech and strategic.

According to Padilha, Anvisa increased by 60% the release of generic drugs in 2011, compared to 2010. The goal is to grant the releases immediately, in the shortest time possible, he said.

The delay in the release of new drugs to the market by ANVISA document theme was delivered yesterday (03) by the Association of Pharmaceutical Industry Research (Interfarma) to the Chief of Staff, Gleisi Hoffman.

This queue two years [pointed by Interfarma] enter all types of medications, including cosmetics. Enter medicines in the public interest, a medication for tuberculosis must leave faster than a cosmetic medicine, eg, Padilla said.

To the minister, a drug for hypertension and diabetes is leaving faster than a drug for a disease that is a public health problem smaller. He further stated that ANVISA is reorganizing processes to accelerate the reporting of other types of drugs.

Source: AGÊNCIA BRASIL
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: Anvisa increased by 60% the release of generics in 2011, says minister
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: Anvisa increased by 60% the release of generics in 2011, says minister


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
generic Anvisa    Alexandre Padilha    Association of Pharmaceutical Research    Interfarma   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.